How to access Skyclarys from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient with a confirmed diagnosis of Friedreich's ataxia may receive a prescription for Skyclarys (omaveloxolone) from their treating neurologist. Skyclarys is FDA-approved as the first disease-specific therapy for Friedreich's ataxia, developed by Biogen (following Reata Pharmaceuticals). Friedreich's ataxia is a progressive autosomal-recessive neurodegenerative condition driven by GAA repeat expansion in the FXN gene, affecting coordination, cardiac function, and (in some patients) glycaemic control. In the UAE, Skyclarys is not locally registered for routine dispensing, which is why your neurologist is likely guiding you toward the UAE Ministry of Health and Prevention (MoHAP) named-patient import pathway.
This guide explains the legal pathway, what documentation your physician needs, typical timing and how quotes work, and where Reserve Meds fits in.
Ask about Skyclarys in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Skyclarys is an oral Nrf2 activator taken once daily. Eligibility is based on genetic confirmation of Friedreich's ataxia (biallelic GAA expansion in FXN) and ongoing management by a neurologist familiar with ataxia and the associated cardiomyopathy surveillance. Your neurologist will confirm diagnosis, run baseline liver function tests, review lipid panels, and coordinate cardiology input. Because Skyclarys is oral, in-country administration is straightforward once the prescribing plan is in place.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Skyclarys legally importable into the UAE?
Yes, through the MoHAP named-patient import framework, administered in coordination with the Ministry of Health for patients treated in public tertiary centres.
The named-patient mechanism allows an Emirati-licensed physician to import a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority such as the US FDA, (b) no clinically equivalent locally registered alternative is available, (c) the physician takes clinical responsibility, and (d) chain of custody is documented end to end. For Friedreich's ataxia, there is no locally registered disease-specific alternative.
How the pathway works, step by step
- Consultation with your treating neurologist. Genetic confirmation of Friedreich's ataxia (biallelic GAA expansion), baseline neurological status (mFARS or equivalent), cardiac assessment, and liver function tests documented.
- Baseline laboratory panel. Liver function, lipid panel, BNP, and glycaemic status established.
- MoHAP named-patient application. Your physician or the hospital pharmacy files the application with clinical rationale, genetic report, patient reference, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure Skyclarys from authorised distribution.
- Shipment. Skyclarys ships with chain-of-custody documentation to the prescribing hospital pharmacy.
- Arrival and dispensing. The hospital pharmacy releases the bottle with dosing instructions; neurology and cardiology monitoring are scheduled.
What documentation your physician needs
Your physician will typically need to provide:
- A clinical rationale letter confirming Friedreich's ataxia diagnosis, genetic report, baseline mFARS / cardiac status, and Skyclarys as the indicated treatment
- Verification of their UAE medical licence (SCFHS / MOH)
- A copy of the FXN genetic diagnostic report
- Patient identifier (anonymised reference where possible)
- An administration and monitoring plan including liver function, lipid, and cardiac surveillance
Reserve Meds provides a physician documentation kit that bundles the templates MoHAP reviewers expect to see for rare-neurology named-patient imports, including the liver-function and cardiac-surveillance plan central to Skyclarys long-term use.
Costs and timing
Medicine price: quote on request. You get a written quote for your case before you commit. International logistics, MoHAP documentation handling, and coordination add incremental cost. Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Refills ship on a rolling basis against the monthly dispensing schedule.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
A culturally-aware note: Friedreich's ataxia, as an autosomal-recessive disease, is more common in the UAE than in many Western populations because of consanguineous marriage patterns. Families often have more than one affected sibling and face long-term progressive disability together. Our coordination supports multi-patient families where appropriate, and we work with caregivers, often a mother, older sibling, or spouse, as designated case contacts for refills and clinic coordination.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Skyclarys specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for MoHAP review.
- Logistics. Chain-of-custody shipment coordination to your prescribing hospital pharmacy.
- Dedicated case lead. A named point of contact for the patient and family, managing ongoing refill logistics.
What we do not do: we are not the prescriber, we do not practise medicine, and we are not the dispensing pharmacy. All clinical decisions remain with your treating neurologist and cardiology team.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP named-patient framework with appropriate documentation. See our trust and compliance page.
Is Skyclarys a cure? No. Skyclarys is a disease-modifying therapy shown to slow deterioration on the mFARS scale in pivotal study data. Your neurologist will discuss realistic outcome expectations.
What monitoring is required? Liver function tests at baseline and periodically, lipid panel, BNP for cardiac surveillance, and weight/glycaemic surveillance are standard. Your neurology and cardiology teams set the cadence.
Can adolescents take Skyclarys? FDA labelling covers patients aged 16 years and older. Your neurologist will confirm age-based eligibility.
Will insurance or MoH coverage apply? Cash-pay is the default. Some UAE patients may receive partial MoH or private-insurance consideration on a case-by-case basis; we supply documentation for submission but do not process claims directly.
Next step
For Skyclarys coordination in the UAE, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Composite case examples. This content is for general information and does not constitute medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Skyclarys in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Skyclarys for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Skyclarys in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Skyclarys. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Skyclarys in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Skyclarys to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Skyclarys to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Skyclarys in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Skyclarys in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.